(AUSTIN) — The Cancer Prevention and Research Institute of Texas (CPRIT) announced 73 new cancer research and prevention grants totaling over $142 million. The projects approved today include 62 academic research grant awards, nine prevention awards,
and two product development research awards awarded to 24 institutions and companies across the state. These awards will expand access to clinical trials, incubate innovative cancer research, support the state’s emerging biotechnology industry,
provide needed cancer screenings for underserved Texans and recruit outstanding cancer researchers to Texas.
“Today illustrates the powerful return on Texas’ investment in cancer research and prevention,” explained Wayne Roberts, CPRIT’s Chief Executive Officer. “Not only is the state enhancing its reputation as the center for innovative
cancer research with more than 250 preeminent scientists recruited to Texas through our CPRIT Scholar program, but the eight new clinical trial grants will expand Texans’ access to promising cancer treatments.”
About the Cancer Prevention and Research Institute of Texas
To date, CPRIT has awarded $2.9 billion in grants to Texas research institutions and organizations through its academic research, prevention and product development research programs. CPRIT has recruited 237 distinguished researchers, supported the establishment,
expansion or relocation of 43 companies to Texas and generated over $5.7 billion in additional public and private investment. CPRIT funding has advanced scientific and clinical knowledge and provided 7.4 million life-saving cancer prevention and early
detection services reaching Texans from all 254 counties. On November 5, 2019, Texas voters overwhelmingly approved a constitutional amendment to provide an additional $3 billion to CPRIT for a total $6 billion investment in cancer research and prevention.
Learn more at https://cprit.texas.gov/.
Awarded Research Grants
Expansion of Cancer Prevention Services to Rural and Medically Underserved Populations Awards - Two grants totaling $4,497,017
The University of Texas Medical Branch at Galveston
- Vaccinating Medically Underserved Women Against HPV: Expansion of Clinical Services to Increase Access (Abbey Berenson) - $1,999,988